CN113648255A - Plant-based product for delaying senescence and preparation method thereof - Google Patents
Plant-based product for delaying senescence and preparation method thereof Download PDFInfo
- Publication number
- CN113648255A CN113648255A CN202110996970.1A CN202110996970A CN113648255A CN 113648255 A CN113648255 A CN 113648255A CN 202110996970 A CN202110996970 A CN 202110996970A CN 113648255 A CN113648255 A CN 113648255A
- Authority
- CN
- China
- Prior art keywords
- parts
- oil
- plant
- based product
- essence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000009758 senescence Effects 0.000 title claims abstract description 26
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 241000196324 Embryophyta Species 0.000 claims abstract description 33
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 33
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims abstract description 22
- 102000008186 Collagen Human genes 0.000 claims abstract description 20
- 108010035532 Collagen Proteins 0.000 claims abstract description 20
- 229920001436 collagen Polymers 0.000 claims abstract description 20
- WVXRAFOPTSTNLL-NKWVEPMBSA-N 2',3'-dideoxyadenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1CC[C@@H](CO)O1 WVXRAFOPTSTNLL-NKWVEPMBSA-N 0.000 claims abstract description 19
- 235000014837 Malpighia glabra Nutrition 0.000 claims abstract description 19
- 241000168517 Haematococcus lacustris Species 0.000 claims abstract description 14
- 239000011159 matrix material Substances 0.000 claims abstract description 13
- 239000000843 powder Substances 0.000 claims abstract description 13
- 239000000049 pigment Substances 0.000 claims abstract description 12
- 235000011187 glycerol Nutrition 0.000 claims abstract description 11
- 235000010355 mannitol Nutrition 0.000 claims abstract description 11
- 239000001341 hydroxy propyl starch Substances 0.000 claims abstract description 9
- 235000013828 hydroxypropyl starch Nutrition 0.000 claims abstract description 9
- 239000008213 purified water Substances 0.000 claims abstract description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 9
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 8
- 235000003599 food sweetener Nutrition 0.000 claims abstract description 8
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 8
- 239000003765 sweetening agent Substances 0.000 claims abstract description 8
- 239000004480 active ingredient Substances 0.000 claims abstract description 7
- 239000000853 adhesive Substances 0.000 claims abstract description 6
- 230000001070 adhesive effect Effects 0.000 claims abstract description 6
- 239000000463 material Substances 0.000 claims abstract description 6
- 239000003921 oil Substances 0.000 claims description 26
- 235000019198 oils Nutrition 0.000 claims description 26
- 240000003394 Malpighia glabra Species 0.000 claims description 18
- 239000011162 core material Substances 0.000 claims description 15
- 239000011248 coating agent Substances 0.000 claims description 10
- 238000000576 coating method Methods 0.000 claims description 10
- -1 diglycerol fatty acid ester Chemical class 0.000 claims description 10
- 238000007710 freezing Methods 0.000 claims description 10
- 229960005150 glycerol Drugs 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 10
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 8
- 239000000243 solution Substances 0.000 claims description 8
- 235000005979 Citrus limon Nutrition 0.000 claims description 7
- 244000131522 Citrus pyriformis Species 0.000 claims description 7
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 7
- 239000003292 glue Substances 0.000 claims description 7
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 7
- 239000000811 xylitol Substances 0.000 claims description 7
- 235000010447 xylitol Nutrition 0.000 claims description 7
- 229960002675 xylitol Drugs 0.000 claims description 7
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 6
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 6
- 239000011259 mixed solution Substances 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 claims description 5
- 241000167854 Bourreria succulenta Species 0.000 claims description 5
- 235000013793 astaxanthin Nutrition 0.000 claims description 5
- 239000001168 astaxanthin Substances 0.000 claims description 5
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 claims description 5
- 229940022405 astaxanthin Drugs 0.000 claims description 5
- 235000019693 cherries Nutrition 0.000 claims description 5
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 5
- 239000000194 fatty acid Substances 0.000 claims description 5
- 229930195729 fatty acid Natural products 0.000 claims description 5
- 239000000845 maltitol Substances 0.000 claims description 5
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 claims description 5
- 235000010449 maltitol Nutrition 0.000 claims description 5
- 229940035436 maltitol Drugs 0.000 claims description 5
- 241000251468 Actinopterygii Species 0.000 claims description 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 4
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 4
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 4
- 229930003268 Vitamin C Natural products 0.000 claims description 4
- 239000010495 camellia oil Substances 0.000 claims description 4
- FDSDTBUPSURDBL-LOFNIBRQSA-N canthaxanthin Chemical compound CC=1C(=O)CCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)CCC1(C)C FDSDTBUPSURDBL-LOFNIBRQSA-N 0.000 claims description 4
- 239000000600 sorbitol Substances 0.000 claims description 4
- 235000010356 sorbitol Nutrition 0.000 claims description 4
- 229960002920 sorbitol Drugs 0.000 claims description 4
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 4
- 235000019154 vitamin C Nutrition 0.000 claims description 4
- 239000011718 vitamin C Substances 0.000 claims description 4
- 235000005976 Citrus sinensis Nutrition 0.000 claims description 3
- 240000002319 Citrus sinensis Species 0.000 claims description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 3
- 108010038807 Oligopeptides Proteins 0.000 claims description 3
- 102000015636 Oligopeptides Human genes 0.000 claims description 3
- 239000004376 Sucralose Substances 0.000 claims description 3
- 235000019498 Walnut oil Nutrition 0.000 claims description 3
- 235000013361 beverage Nutrition 0.000 claims description 3
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 claims description 3
- 235000011086 calcium lactate Nutrition 0.000 claims description 3
- 239000001527 calcium lactate Substances 0.000 claims description 3
- 229960002401 calcium lactate Drugs 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 229920001971 elastomer Polymers 0.000 claims description 3
- IINNWAYUJNWZRM-UHFFFAOYSA-L erythrosin B Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(I)C(=O)C(I)=C2OC2=C(I)C([O-])=C(I)C=C21 IINNWAYUJNWZRM-UHFFFAOYSA-L 0.000 claims description 3
- 235000012732 erythrosine Nutrition 0.000 claims description 3
- 239000004174 erythrosine Substances 0.000 claims description 3
- 229940011411 erythrosine Drugs 0.000 claims description 3
- 230000008014 freezing Effects 0.000 claims description 3
- 239000008103 glucose Substances 0.000 claims description 3
- 239000000944 linseed oil Substances 0.000 claims description 3
- 235000021388 linseed oil Nutrition 0.000 claims description 3
- 239000004006 olive oil Substances 0.000 claims description 3
- 235000008390 olive oil Nutrition 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- 235000019408 sucralose Nutrition 0.000 claims description 3
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims description 3
- 239000004408 titanium dioxide Substances 0.000 claims description 3
- 239000008170 walnut oil Substances 0.000 claims description 3
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 3
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 claims description 2
- 240000001592 Amaranthus caudatus Species 0.000 claims description 2
- 235000009328 Amaranthus caudatus Nutrition 0.000 claims description 2
- 244000099147 Ananas comosus Species 0.000 claims description 2
- 235000007119 Ananas comosus Nutrition 0.000 claims description 2
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 claims description 2
- 241000195493 Cryptophyta Species 0.000 claims description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 2
- 241000208688 Eucommia Species 0.000 claims description 2
- 239000005715 Fructose Substances 0.000 claims description 2
- 229930091371 Fructose Natural products 0.000 claims description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims description 2
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims description 2
- 244000291473 Musa acuminata Species 0.000 claims description 2
- 235000019482 Palm oil Nutrition 0.000 claims description 2
- 235000019483 Peanut oil Nutrition 0.000 claims description 2
- OOUTWVMJGMVRQF-DOYZGLONSA-N Phoenicoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C(=O)C(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)C(=O)CCC2(C)C OOUTWVMJGMVRQF-DOYZGLONSA-N 0.000 claims description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 2
- 240000003768 Solanum lycopersicum Species 0.000 claims description 2
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 2
- 229930006000 Sucrose Natural products 0.000 claims description 2
- 244000299461 Theobroma cacao Species 0.000 claims description 2
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 claims description 2
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 claims description 2
- 240000000851 Vaccinium corymbosum Species 0.000 claims description 2
- 235000003095 Vaccinium corymbosum Nutrition 0.000 claims description 2
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims description 2
- 235000012741 allura red AC Nutrition 0.000 claims description 2
- 239000004191 allura red AC Substances 0.000 claims description 2
- 235000012735 amaranth Nutrition 0.000 claims description 2
- 239000004178 amaranth Substances 0.000 claims description 2
- 235000010208 anthocyanin Nutrition 0.000 claims description 2
- 239000004410 anthocyanin Substances 0.000 claims description 2
- 229930002877 anthocyanin Natural products 0.000 claims description 2
- 150000004636 anthocyanins Chemical class 0.000 claims description 2
- 235000012733 azorubine Nutrition 0.000 claims description 2
- TVWOWDDBXAFQDG-DQRAZIAOSA-N azorubine Chemical compound C1=CC=C2C(\N=N/C3=C(C4=CC=CC=C4C(=C3)S(O)(=O)=O)O)=CC=C(S(O)(=O)=O)C2=C1 TVWOWDDBXAFQDG-DQRAZIAOSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- 235000021014 blueberries Nutrition 0.000 claims description 2
- 210000000988 bone and bone Anatomy 0.000 claims description 2
- 235000001046 cacaotero Nutrition 0.000 claims description 2
- 235000012682 canthaxanthin Nutrition 0.000 claims description 2
- 239000001659 canthaxanthin Substances 0.000 claims description 2
- 229940008033 canthaxanthin Drugs 0.000 claims description 2
- 235000012730 carminic acid Nutrition 0.000 claims description 2
- 235000005473 carotenes Nutrition 0.000 claims description 2
- 150000001746 carotenes Chemical class 0.000 claims description 2
- OIQPTROHQCGFEF-UHFFFAOYSA-L chembl1371409 Chemical compound [Na+].[Na+].OC1=CC=C2C=C(S([O-])(=O)=O)C=CC2=C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 OIQPTROHQCGFEF-UHFFFAOYSA-L 0.000 claims description 2
- CEZCCHQBSQPRMU-UHFFFAOYSA-L chembl174821 Chemical compound [Na+].[Na+].COC1=CC(S([O-])(=O)=O)=C(C)C=C1N=NC1=C(O)C=CC2=CC(S([O-])(=O)=O)=CC=C12 CEZCCHQBSQPRMU-UHFFFAOYSA-L 0.000 claims description 2
- 235000005687 corn oil Nutrition 0.000 claims description 2
- 239000002285 corn oil Substances 0.000 claims description 2
- 235000013399 edible fruits Nutrition 0.000 claims description 2
- 229960002737 fructose Drugs 0.000 claims description 2
- 229960001031 glucose Drugs 0.000 claims description 2
- 235000001727 glucose Nutrition 0.000 claims description 2
- 239000000832 lactitol Substances 0.000 claims description 2
- 235000010448 lactitol Nutrition 0.000 claims description 2
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 claims description 2
- 229960003451 lactitol Drugs 0.000 claims description 2
- 229930189775 mogroside Natural products 0.000 claims description 2
- 239000002540 palm oil Substances 0.000 claims description 2
- 239000000312 peanut oil Substances 0.000 claims description 2
- 150000003904 phospholipids Chemical class 0.000 claims description 2
- 235000013772 propylene glycol Nutrition 0.000 claims description 2
- 239000002151 riboflavin Substances 0.000 claims description 2
- 235000019192 riboflavin Nutrition 0.000 claims description 2
- 229960002477 riboflavin Drugs 0.000 claims description 2
- 239000008159 sesame oil Substances 0.000 claims description 2
- 235000011803 sesame oil Nutrition 0.000 claims description 2
- 239000003549 soybean oil Substances 0.000 claims description 2
- 235000012424 soybean oil Nutrition 0.000 claims description 2
- 229940013618 stevioside Drugs 0.000 claims description 2
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims description 2
- 235000019202 steviosides Nutrition 0.000 claims description 2
- 239000005720 sucrose Substances 0.000 claims description 2
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 claims description 2
- 239000012299 nitrogen atmosphere Substances 0.000 claims 1
- 241001640002 Malpighia emarginata Species 0.000 abstract 1
- 235000009508 confectionery Nutrition 0.000 abstract 1
- 230000001804 emulsifying effect Effects 0.000 abstract 1
- 230000000873 masking effect Effects 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
- 230000032683 aging Effects 0.000 description 19
- 210000003491 skin Anatomy 0.000 description 13
- 230000000694 effects Effects 0.000 description 8
- 150000003254 radicals Chemical class 0.000 description 6
- 230000007423 decrease Effects 0.000 description 5
- 230000009759 skin aging Effects 0.000 description 5
- 238000000034 method Methods 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 230000037303 wrinkles Effects 0.000 description 4
- 206010013786 Dry skin Diseases 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 230000003292 diminished effect Effects 0.000 description 3
- 230000036737 immune function Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 230000035790 physiological processes and functions Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 102000016942 Elastin Human genes 0.000 description 2
- 108010014258 Elastin Proteins 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000007850 degeneration Effects 0.000 description 2
- 230000005786 degenerative changes Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000037336 dry skin Effects 0.000 description 2
- 229920002549 elastin Polymers 0.000 description 2
- 210000001339 epidermal cell Anatomy 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 210000002510 keratinocyte Anatomy 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 230000005778 DNA damage Effects 0.000 description 1
- 231100000277 DNA damage Toxicity 0.000 description 1
- 206010051246 Photodermatosis Diseases 0.000 description 1
- 206010040844 Skin exfoliation Diseases 0.000 description 1
- 206010040954 Skin wrinkling Diseases 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 201000010251 cutis laxa Diseases 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 230000035618 desquamation Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000007368 endocrine function Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000007968 orange flavor Substances 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000008845 photoaging Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000004800 psychological effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9706—Algae
- A61K8/9722—Chlorophycota or Chlorophyta [green algae], e.g. Chlorella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/84—Products or compounds obtained by lyophilisation, freeze-drying
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
Abstract
The plant-based product for delaying senescence is prepared from the following components in parts by weight: 1-5 parts of collagen peptide, 4-20 parts of haematococcus pluvialis oil, 0.6-3 parts of emulsifier, 2.4-12 parts of acerola powder and 25-125 parts of matrix oil; the adhesive also comprises the following auxiliary materials in parts by weight: 5000-10000 parts of hydroxypropyl starch, 1500-3000 parts of glycerol, 6000-12000 parts of purified water, 350-700 parts of D-mannitol, 100-200 parts of edible pigment, 1.25-2.5 parts of sweetening agent and 325-650 parts of edible essence. The plant-based product for delaying senescence is coated by the plant gum and the matrix oil, so that the stability of active ingredients is effectively guaranteed, the contents of the active ingredients and the like are improved to a certain extent, and the bioavailability of the active ingredients is greatly improved. The invention also discloses a preparation method of the plant-based product, the plant-based product is prepared by utilizing an embedding technology, an emulsifying technology and a taste masking technology in the preparation technology, the taste is sour, sweet and delicious, the problem of instability of raw materials is solved, the active ingredients are easy to absorb, and the bioavailability and the quality stability of the product are improved.
Description
Technical Field
The invention relates to a plant-based product for delaying senescence and a preparation method thereof, belonging to the field of health-care medicines and foods.
Background
Human aging is a natural law and cannot be avoided by people. The growth and development process of human can be divided into three processes of growth, maturation and degeneration. Aging is a degenerative change that occurs in various organs, tissues and cells of the human body during the degenerative phase. These degenerative changes can cause the decline of human physiological functions, so that the elderly are prone to suffer from various diseases and the aging speed of the whole body is accelerated. Senescence is the result of a combination of factors, and is generally divided into physiological senescence and psychological senescence. Physiological aging can be seen from the aspects of age, appearance, voice, eyesight improving action, etc., and the physiological aging is related to various tissues, organs and systems, and influences various physiological functions and vital activities of people. Human aging is also closely related to free radicals in the body. In the metabolism process of human body, several kinds of free radicals, also called free radicals, are produced, which are some chemical molecular groups or atomic groups, and have strong oxidation in the body, and excessive free radicals can damage the normal tissues and cells of the human body, causing the rapid aging of the human body. In addition, the strength of the immune function of the human body is also a determinant factor of the aging speed. With age, the immune function of a human decreases and the rate of aging increases.
The skin is the largest organ of the human body and has the functions of protecting, feeling, regulating the body temperature, secreting, excreting, immunizing and the like. With aging, the skin is also aged gradually like other organs of the human body, and functions are weakened and lost, and various diseases are caused. Aged skin, apparently characterized by skin laxity and appearance of wrinkles, especially skin roughness, wrinkles deepening and thickening in exposed areas of the body; abnormal epidermal structure, pigmentation; the skin elasticity is not changed and becomes loose; vasodilation, epidermal dyskeratosis, and the like. In aging skin, epidermal cell renewal is slowed, barrier function is diminished, keratinocyte viability is reduced, and repair ability of the epidermis is diminished after injury, wherein the diminished barrier function results in dry skin, desquamation, wrinkles, and the like. The number of fibroblasts in the dermis layer of aging skin gradually decreases, and the ability to synthesize collagen and elastin decreases, resulting in rough, dry skin.
Because aging has complex psychological and physiological effects on people's life and work, it can cause a series of psychological problems such as anxiety, depression, inferior and so on, therefore, the treatment of delaying aging, especially the treatment of delaying aging of skin, has been one of the focuses of people's research. The mechanisms of skin aging have been studied very much, and thirty theories have appeared in turn, wherein the theories are more representative such as: the theory of free radical senescence, the theory of metabolic disorders, the theory of gene regulation, the theory of photoaging, the theory of mitochondria, the theory of immune function degeneration, the theory of endocrine function decline, the theory of non-enzymatic glycosylation senescence, the theory of cross-linking, the theory of carboxyl-poisoning senescence, the theory of DNA damage accumulation, the theory of apoptosis, and the like. Although there are many theories about skin aging, and each theory has a certain theoretical and experimental basis, skin aging is a complex process with multiple layers and aspects, and a product for delaying aging developed according to the single mechanism only plays a role in delaying aging from one layer to another, and the effect is not obvious. Therefore, in order to develop a product with more outstanding efficacy for delaying aging, multiple layers, multiple angles and multiple ways are needed for delaying skin aging.
At present, products developed according to the idea are not many, and a plurality of cosmetics compounded with various anti-aging active ingredients are already provided by a plurality of large international brands. Traditionally, people focus on the use of cosmetics to improve the condition of skin, but nowadays more and more people begin to focus on the internal conditioning of the body, and the pursuit for beauty tends to be 'from outside to inside'. A large number of clinical trial researches prove that the content of astaxanthin, collagen and other substances in the skin can be increased by oral administration, and the physiological functions of water retention, oxidation resistance and aging delay can be achieved, so that the skin wrinkle is eliminated, the skin aging is delayed, and the utilization effect is better than that of cosmetics coated on the skin surface.
Disclosure of Invention
The invention aims to overcome the defects of the prior art and provide a plant-based product for delaying senescence and a preparation method thereof, wherein the components have synergistic effect, generate high-efficiency comprehensive effect on antioxidation, and have the advantages of safety, reliability and no toxic or side effect. Aiming at solving the problems, the invention provides the following technical scheme:
the plant-based product for delaying senescence is characterized by being prepared from the following components in parts by weight: 1-5 parts of collagen peptide, 4-20 parts of haematococcus pluvialis oil, 0.6-3 parts of emulsifier, 2.4-12 parts of acerola powder and 25-125 parts of matrix oil;
the adhesive also comprises the following auxiliary materials in parts by weight: 5000-10000 parts of hydroxypropyl starch, 1500-3000 parts of glycerol, 6000-12000 parts of purified water, 350-700 parts of D-mannitol, 100-200 parts of edible pigment, 1.25-2.5 parts of sweetening agent and 325-650 parts of edible essence.
Furthermore, in the plant-based product for delaying senility, the collagen peptide is one or more of fish skin collagen, fish bone collagen and collagen oligopeptide; the acerola powder is one or more of acerola fruit powder, acerola extract and acerola solid beverage; the emulsifier is selected from one or more of monoglyceride and diglycerol fatty acid ester, phospholipid, sucrose fatty acid ester, xylitol anhydride monostearate, polyoxyethylene xylitol anhydride monostearate, calcium lactate, propylene glycol, D-mannitol, maltitol, sorbitol, lactitol and glycerol; the matrix oil is selected from one or more of peanut oil, corn oil, olive oil, camellia oil, palm oil, soybean oil, sesame oil, linseed oil, walnut oil, tea seed oil, eucommia seed oil, DHA algae oil and tomato seed oil; the edible pigment is selected from one or more of titanium dioxide, lemon yellow, brilliant blue, carmine, new red, amaranth, allura red, erythrosine, azorubine, sunset yellow, riboflavin, canthaxanthin, carotene, anthocyanin, and cacao shell pigment; the edible essence comprises one or more of sweet orange essence, cherry essence, blueberry essence, green lemon essence, edible orange essence, edible pineapple essence, edible lemon essence and edible banana essence; the sweetener is selected from more than one of crystalline fructose, glucose, xylitol, sorbitol, maltitol, stevioside, sucralose and mogroside.
Furthermore, in the plant-based product for delaying senility, the haematococcus pluvialis oil mainly contains astaxanthin, and the content of the astaxanthin is 5.0-10.0 percent; the main effective component of the acerola powder is vitamin C, and the content of the vitamin C is 25.0-40.0 percent.
Further, the preparation method of the plant-based product for delaying senescence comprises the following steps:
step one, mixing hydroxypropyl starch with purified water with the temperature of not lower than 80-90 ℃ in parts by weight, and fully stirring to obtain a mixed solution I;
dissolving glycerol and D-mannitol into the mixed solution I in parts by weight, and fully stirring to obtain a mixture II;
thirdly, after the temperature of the mixture II is reduced to 40-50 ℃ according to the parts by weight, sequentially dissolving the edible pigment, the sweetening agent and the edible essence into the mixture II according to the parts by weight, and uniformly mixing to prepare a glue solution for later use;
dissolving collagen peptide, acerola powder, haematococcus pluvialis oil and an emulsifier into matrix oil to obtain a core material I for later use;
fifthly, uniformly coating the quick-frozen core material I with matrix oil to prepare a core material II;
and step six, uniformly coating the core agent II in the rubber formed by the glue solution to prepare the plant-based product.
Further, the quick-freezing in the fifth step of the plant-based product for delaying senescence is carried out by adopting a quick-freezing machine, the quick-freezing temperature is-10 ℃ to-20 ℃, the freezing time is 5-20 min, and the central temperature of the core material I is-5 ℃ to-10 ℃.
Further, the plant-based product for delaying senescence is coated by a pelleting machine in the coating step six, the temperature of a spray body of the pelleting machine is controlled to be 15-28 ℃, and the environmental humidity is controlled to be 12-40%.
Furthermore, the first step to the fifth step of the preparation method of the plant-based product for delaying senescence are operated in a nitrogen environment.
The invention has the beneficial effects that:
1. the composition not only has the effects of eliminating excessive free radicals, promoting cell metabolism and supplementing collagen and elastin, but also has the advantages of stimulating the renewal of epidermal cells, relieving the activity of melanocytes, reducing the appearance of color spots, stimulating the shedding of keratinocytes and accelerating the renewal of cells.
2. According to the preparation method of the plant-based product, firstly, haematococcus pluvialis oil dissolved in the plant-based product is coated in matrix oil to play a role in oxygen isolation, and the preparation method is simple; and then, the coating of the glue solution is adopted, so that the stability of the active ingredients is effectively guaranteed, the long-time storage is facilitated, and the quality guarantee period is prolonged.
Detailed Description
The present invention is further described in detail below with reference to examples so that those skilled in the art can practice the invention with reference to the description.
Example 1
A plant-based product for delaying senescence is prepared from the following components in parts by weight: 5 parts of fishskin collagen, 20 parts of haematococcus pluvialis oil, 3 parts of mono-diglycerol fatty acid ester, 12 parts of acerola powder and 125 parts of linseed oil;
the adhesive also comprises the following auxiliary materials in parts by weight: 10000 parts of hydroxypropyl starch, 3000 parts of glycerol, 12000 parts of purified water, 700 parts of D-mannitol, 200 parts of erythrosine, 2.5 parts of sucralose and 650 parts of sweet orange flavor.
Example 2
The plant-based product for delaying senescence is characterized by being prepared from the following components in parts by weight: 1 part of fishbone collagen, 4 parts of haematococcus pluvialis oil, 0.6 part of maltitol, 2.4 parts of acerola cherry extract and 25 parts of olive oil;
the adhesive also comprises the following auxiliary materials in parts by weight: 5000 parts of hydroxypropyl starch, 1500 parts of glycerol, 6000 parts of purified water, 350 parts of D-mannitol, 100 parts of titanium dioxide, 1.25 parts of xylitol and 325 parts of edible lemon essence.
Example 3
The plant-based product for delaying senescence is characterized by being prepared from the following components in parts by weight: 3 parts of collagen oligopeptide, 10 parts of haematococcus pluvialis oil, 2 parts of calcium lactate, 6 parts of acerola cherry solid beverage and 80 parts of walnut oil;
the adhesive also comprises the following auxiliary materials in parts by weight: 8000 parts of hydroxypropyl starch, 2000 parts of glycerol, 10000 parts of purified water, 500 parts of D-mannitol, 120 parts of sunset yellow, 2 parts of glucose and 450 parts of lime flavor.
Example 4
Example 1, example 2 and example 3, plant-based products were prepared according to the following procedure, including the following steps:
step one, mixing hydroxypropyl starch and purified water with the temperature of not lower than 80-90 ℃ in parts by weight, and fully stirring to obtain a mixed solution I.
And step two, dissolving the glycerol and the D-mannitol into the mixed solution I according to the parts by weight, and fully stirring to obtain a mixture II.
And step three, after the temperature of the mixture II is reduced to 40-50 ℃ according to the parts by weight, sequentially dissolving the edible pigment, the sweetening agent and the edible essence into the mixture II according to the parts by weight, and uniformly mixing to prepare a glue solution for later use.
And step four, dissolving the collagen peptide, the acerola powder, the haematococcus pluvialis oil and the emulsifier into the matrix oil according to the parts by weight to obtain the core material I for later use.
Fifthly, uniformly coating the quick-frozen core material I with matrix oil to prepare a core material II; the quick-freezing temperature is-10 ℃ to-20 ℃, the freezing time is 5-20 min, and the central temperature of the core material I is-5 ℃ to-10 ℃.
Step six, uniformly coating the core agent II in the rubber formed by the glue solution to prepare the plant-based product. The coating is carried out by a pelleting press, the temperature of a spray body of the pelleting press is controlled to be 15-28 ℃, and the ambient humidity is controlled to be 12-40%.
And all the first step to the fifth step are operated under the inert gas environment.
Test example 1 trial observation was carried out on 100 subjects, and 50 men and women, each aged 20 to 45 years, had regular diet and rest, and had no adverse taste (such as smoking and drinking). The test groups were divided into 4 groups, and the experimental group used the products prepared in examples 1 to 3 of the present invention, while the control group used the haematococcus pluvialis oil product for more than one month. The improvement of skin moisture, elasticity, pores, color spots, textures, roughness, acne, pigments and ultraviolet spots is taken as a standard, the improvement of the skin moisture, elasticity, pores, color spots, texture, roughness, acne, pigments and ultraviolet spots is preferably achieved by more than 8 standards, is good by 6-7 standards, is poor by 4-5 standards, and is less than 3 standards or has no obvious improvement, and the observation result is shown in the table below.
The excellent standard reaching rate of the tested person using the product group of the invention is obviously higher than that of the control group, which shows that the effect of the plant-based product of the invention is better than that of the haematococcus pluvialis oil product. The superiority of the invention is proved.
The above description is only for the preferred embodiment of the present invention, but the scope of the present invention is not limited thereto, and any person skilled in the art should be considered to be within the technical scope of the present invention, and the technical solutions and the inventive concepts thereof according to the present invention should be equivalent or changed within the scope of the present invention.
Claims (7)
1. The plant-based product for delaying senescence is characterized by being prepared from the following components in parts by weight: 1-5 parts of collagen peptide, 4-20 parts of haematococcus pluvialis oil, 0.6-3 parts of emulsifier, 2.4-12 parts of acerola powder and 25-125 parts of matrix oil;
the adhesive also comprises the following auxiliary materials in parts by weight: 5000-10000 parts of hydroxypropyl starch, 1500-3000 parts of glycerol, 6000-12000 parts of purified water, 350-700 parts of D-mannitol, 100-200 parts of edible pigment, 1.25-2.5 parts of sweetening agent and 325-650 parts of edible essence.
2. The senescence delaying plant-based product according to claim 1, wherein the collagen peptide is one or more of fish skin collagen, fish bone collagen and collagen oligopeptide; the acerola powder is one or more of acerola fruit powder, acerola extract and acerola solid beverage; the emulsifier is selected from one or more of monoglyceride and diglycerol fatty acid ester, phospholipid, sucrose fatty acid ester, xylitol anhydride monostearate, polyoxyethylene xylitol anhydride monostearate, calcium lactate, propylene glycol, D-mannitol, maltitol, sorbitol, lactitol and glycerol; the matrix oil is selected from one or more of peanut oil, corn oil, olive oil, camellia oil, palm oil, soybean oil, sesame oil, linseed oil, walnut oil, tea seed oil, eucommia seed oil, DHA algae oil and tomato seed oil; the edible pigment is selected from one or more of titanium dioxide, lemon yellow, brilliant blue, carmine, new red, amaranth, allura red, erythrosine, azorubine, sunset yellow, riboflavin, canthaxanthin, carotene, anthocyanin, and cacao shell pigment; the edible essence comprises one or more of sweet orange essence, cherry essence, blueberry essence, green lemon essence, edible orange essence, edible pineapple essence, edible lemon essence and edible banana essence; the sweetener is selected from more than one of crystalline fructose, glucose, xylitol, sorbitol, maltitol, stevioside, sucralose and mogroside.
3. The senescence delaying plant-based product according to claim 2, wherein the haematococcus pluvialis oil comprises astaxanthin as a main active ingredient, and the content of astaxanthin is 5.0% to 10.0%; the main effective component of the acerola cherry powder is vitamin C, and the content of the vitamin C is 25.0-40.0.
4. The senescence delaying plant-based product according to claims 1 to 3, wherein the preparation method of the plant-based product comprises the following steps:
step one, mixing hydroxypropyl starch with purified water with the temperature of not lower than 80-90 ℃ in parts by weight, and fully stirring to obtain a mixed solution I;
dissolving glycerol and D-mannitol into the mixed solution I in parts by weight, and fully stirring to obtain a mixture II;
thirdly, after the temperature of the mixture II is reduced to 40-50 ℃ according to the parts by weight, sequentially dissolving the edible pigment, the sweetening agent and the edible essence into the mixture II according to the parts by weight, and uniformly mixing to prepare a glue solution for later use;
dissolving collagen peptide, acerola powder, haematococcus pluvialis oil and an emulsifier into matrix oil to obtain a core material I for later use;
fifthly, uniformly coating the quick-frozen core material I with matrix oil to prepare a core material II;
and step six, uniformly coating the core agent II in the rubber formed by the glue solution to prepare the plant-based product.
5. The plant-based product for delaying senescence according to claim 4, wherein the quick-freezing in the fifth step is carried out by a quick-freezing machine, the quick-freezing temperature is-10 ℃ to-20 ℃, the freezing time is 5-20 min, and the temperature reaches-5 ℃ to-10 ℃ in the center of the core material I.
6. The senescence-delaying plant-based product according to claim 4, wherein the coating in the sixth step is performed by a pelleting machine, the temperature of the body sprayed by the pelleting machine is controlled to be 15-28 ℃, and the ambient humidity is controlled to be 12-40%.
7. The senescence delaying plant-based product according to claim 4, wherein the steps one to five are all operated under a nitrogen atmosphere.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110996970.1A CN113648255A (en) | 2021-08-27 | 2021-08-27 | Plant-based product for delaying senescence and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110996970.1A CN113648255A (en) | 2021-08-27 | 2021-08-27 | Plant-based product for delaying senescence and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113648255A true CN113648255A (en) | 2021-11-16 |
Family
ID=78493133
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110996970.1A Pending CN113648255A (en) | 2021-08-27 | 2021-08-27 | Plant-based product for delaying senescence and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113648255A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114601172A (en) * | 2022-03-10 | 2022-06-10 | 山东若尧特医食品有限公司 | Formula food of glutamine composition with special medical application and preparation method thereof |
| CN114869835A (en) * | 2022-06-30 | 2022-08-09 | 广州长生康生物科技有限公司 | Fullerene placenta essence and preparation method thereof |
| CN116491615A (en) * | 2023-05-17 | 2023-07-28 | 哈尔滨三联药业股份有限公司 | Meinaria oil collagen peptide beverage composition and preparation method thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102726738A (en) * | 2012-06-12 | 2012-10-17 | 广东仙乐制药有限公司 | Health-caring composition and health-caring product with iron supplementation function, and preparation method thereof |
| CN107549812A (en) * | 2017-10-16 | 2018-01-09 | 海南三元星生物科技股份有限公司 | It is a kind of using acerola concentrate extract, haematococcus pluvialis and Isin glue collagen peptide as beautifying and anti-aging food of raw material and preparation method thereof |
| CN108404122A (en) * | 2018-04-24 | 2018-08-17 | 石家庄瑞大圣康生物科技有限公司 | A kind of composition and its technology of preparing of anti-aging |
| CN109105690A (en) * | 2018-09-18 | 2019-01-01 | 广州市爱百伊生物技术有限公司 | A kind of fruity beverage and its processing method containing collagen peptide |
| CN112842967A (en) * | 2021-03-05 | 2021-05-28 | 广州正广生物科技有限公司 | Anti-aging composition with function of removing free radicals and preparation method thereof |
-
2021
- 2021-08-27 CN CN202110996970.1A patent/CN113648255A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102726738A (en) * | 2012-06-12 | 2012-10-17 | 广东仙乐制药有限公司 | Health-caring composition and health-caring product with iron supplementation function, and preparation method thereof |
| CN107549812A (en) * | 2017-10-16 | 2018-01-09 | 海南三元星生物科技股份有限公司 | It is a kind of using acerola concentrate extract, haematococcus pluvialis and Isin glue collagen peptide as beautifying and anti-aging food of raw material and preparation method thereof |
| CN108404122A (en) * | 2018-04-24 | 2018-08-17 | 石家庄瑞大圣康生物科技有限公司 | A kind of composition and its technology of preparing of anti-aging |
| CN109105690A (en) * | 2018-09-18 | 2019-01-01 | 广州市爱百伊生物技术有限公司 | A kind of fruity beverage and its processing method containing collagen peptide |
| CN112842967A (en) * | 2021-03-05 | 2021-05-28 | 广州正广生物科技有限公司 | Anti-aging composition with function of removing free radicals and preparation method thereof |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114601172A (en) * | 2022-03-10 | 2022-06-10 | 山东若尧特医食品有限公司 | Formula food of glutamine composition with special medical application and preparation method thereof |
| CN114601172B (en) * | 2022-03-10 | 2024-03-19 | 山东若尧特医食品有限公司 | Formula food with special medical application of glutamine composition and preparation method thereof |
| CN114869835A (en) * | 2022-06-30 | 2022-08-09 | 广州长生康生物科技有限公司 | Fullerene placenta essence and preparation method thereof |
| CN116491615A (en) * | 2023-05-17 | 2023-07-28 | 哈尔滨三联药业股份有限公司 | Meinaria oil collagen peptide beverage composition and preparation method thereof |
| CN116491615B (en) * | 2023-05-17 | 2023-09-12 | 哈尔滨三联药业股份有限公司 | Meinaria oil collagen peptide beverage composition and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN113648255A (en) | Plant-based product for delaying senescence and preparation method thereof | |
| KR101810231B1 (en) | Cosmetic composition for improving acne containing propolis spicule powder | |
| US10149809B2 (en) | Skin aging inhibitor and concentrate of resveratrol 3-O-α-glucoside | |
| MX2011001183A (en) | Method of preparing a muscadine pomace extract. | |
| US20090269424A1 (en) | Peripheral blood flow-improving composition | |
| KR101712608B1 (en) | - Composition for comprising -terpineol for moisturizing and improving skin wrinkle | |
| WO2019100923A1 (en) | Skin care composition and application thereof, and health care product | |
| JP2002003393A (en) | Fibroblast growth agent, food and drink for beauty culture and skin cosmetic | |
| JP2002003390A (en) | Fibroblast growth agent, food and drink for beauty culture and skin cosmetic | |
| EP1961408A2 (en) | Cosmetic combination product for improving the external appearance | |
| KR101965595B1 (en) | Composition for prevention of losing hair or promotion of growing hair | |
| KR101437997B1 (en) | Fermented caviar extract and its cosmetic usage | |
| US20080020067A1 (en) | Skin Moisturizer | |
| KR102343112B1 (en) | Anti-aging composition comprising functional peptides, amino acids, callus extract and fermented materials | |
| KR20110015866A (en) | Composition containing concentrated makgeolli for antioxidation and whitening effect | |
| KR101721022B1 (en) | Composition for comprising adipic acid for improving skin wrinkle or enhancing skin elasticity | |
| KR101965594B1 (en) | Composition for prevention of losing hair or promotion of growing hair comprising bean extract | |
| KR100768830B1 (en) | Extract of echinosophora koreensis removing hangover and having anti-oxidant activity | |
| JP2001316275A (en) | Collagen production promoter, estrogen-like agent, collagenase inhibitor, skin cosmetic, food and drink | |
| WO2023113111A1 (en) | Skin whitening composition for relieving melasma, age spots, etc. using water-soluble mastic gum | |
| KR100758266B1 (en) | Extract of chrysanthemum zawadskii removing hangover and having anti-oxidant activity | |
| CN112586740A (en) | Protein product and preparation method thereof | |
| CN106389141A (en) | Skin improving composition | |
| KR102602321B1 (en) | Cosmetic composition for preventing or improving hair loss symptoms containing black soybean, green tangerine and turmeric extract | |
| CN112584820A (en) | Cosmetic composition for skin moisture containing thyme complex extract as active ingredient |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20211116 |